Avicanna Inc. (TSX:AVCN)

Canada · Delayed Price · Currency is CAD

0.1500

0.00 (0.00%)

Apr 10, 2026, 3:59 PM EST

Revenue by Segment

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals	25.48M	25.46M	16.79M	4.05M	3.27M
Pharmaceuticals Growth	0.08%	51.62%	314.82%	23.83%	108.20%
Total	25.48M	25.46M	16.79M	4.05M	3.27M
Total Growth	0.08%	51.62%	314.82%	23.83%	108.20%

Revenue by Geography

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
International	1.89M	1.92M	364.42K	-	-
International Growth	-1.85%	427.59%	-	-	-
Canada	23.59M	23.54M	16.43M	-	-
Canada Growth	0.23%	43.28%	-	-	-
South America	-	-	-	1.03M	981.50K
South America Growth	-	-	-	4.96%	-
North America	-	-	-	2.98M	2.26M
North America Growth	-	-	-	32.18%	-
Rest of World	-	-	-	35.41K	31.19K
Rest of World Growth	-	-	-	13.51%	-
Total	25.48M	25.46M	16.79M	4.05M	3.27M
Total Growth	0.08%	51.62%	314.82%	23.83%	-

Source: S&P Global Market Intelligence.